Buprenorphine Sublingual Tablets, 8 mg, 30 count-bottles, Rx only, Manufactured by: Sun Pharma, NDC 62756-460-83.
Published June 14, 2023 · Recall initiated: May 3, 2023
Summary
FDA records drug Class II recall D-0869-2023, published June 14, 2023 and initiated May 3, 2023. Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC; Status: Terminated; Reported quantity: 12,336 bottles; Lot: Lot #: DND1515A, Exp 08/24. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations
What to do
Voluntary: Firm initiated · Letter
Get an email if BUPRENORPHINE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- BUPRENORPHINE
- Manufacturer
- SUN PHARMACEUTICAL INDUSTRIES INC
- Distributor
- Product was distributed to 19 distributors nationwide.
- Lot
- Lot #: DND1515A, Exp 08/24
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDABuprenorphine Sublingual Tablets (C-III), 2 mg, 30 Tablets (3x10), Rx only, Distributed by: American HealthSeptember 9, 2026
- FDATravoprost Ophthalmic Solution, USP (Ionic Buffered Solution), 0.004%, Rx only, Manufactured by Apotex Inc.,June 14, 2023
- FDAGLYCOPYRROLATE INJECTION, USP 0.2MG/ML, 1mL VIAL, manufactured by HF Acquisition Co. LLC, Mukilteo, WA 98275,June 14, 2023
- FDALevsin injection (hyoscyamine sulfate injection, USP), 0.5 mg per ml in water for Injection, 1 ml Ampule (BoxJune 14, 2023
- FDAsimply to go Strawberry Yogurt Parfaits, 8.53oz, UPC 477088125794; packaged in plastic cupsJune 14, 2023
- FDABuprenorphine Transdermal System 5 mcg/hour, 4 transdermal systems/4 disposal units per carton, Rx Only,October 7, 2020
Questions about this recall
Was Buprenorphine Sublingual Tablets, 8 mg, 30 count-bottles, Rx only, Manufactured by: Sun Pharma, NDC 62756-460-83. recalled?
Yes. FDA published recall D-0869-2023 on June 14, 2023. Reported hazard: CGMP Deviations
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: BUPRENORPHINE.